Approvals/NMPA/Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection(50R)

Approved

生物制品

Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection(50R)

Eli Lilly Nederland BV🇨🇳 National Medical Products Administration

Approval Id: 8Iee18eIhtV
Approval Number: 国药准字SJ20171023
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(50R)
Generic Name En: Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection(50R)
Trade Name: 优泌乐50
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(预装注射笔)
Reg Date: 2022-07-20
Expired Date: 2027-07-19
Company Name: Eli Lilly Nederland BV
Production Company Name: LILLY FRANCE
Company Detail Path: /organization/eli-lilly-nederland-bv
Production Company Detail Path: /organization/lilly-france

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 20, 2022

Approval ID

8Iee18eIhtV

Type

生物制品